Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome

BACKGROUND: Oral tacrolimus is a therapeutic agent for moderate to severe steroid-dependent or resistant ulcerative colitis (UC), but remission induction is difficult, and it is necessary to treat the patient while considering the next treatment. AIM: To examine serum albumin (Alb) level as a progno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Ishida, Natsuki, Miyazu, Takahiro, Tamura, Satoshi, Tani, Shinya, Yamade, Mihoko, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2021
Assuntos:
Retrospective Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8192282/
https://ncbi.nlm.nih.gov/pubmed/34168412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i22.3109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados